News
Raymond James analyst Jayson Bedford lowered the firm’s price target on Johnson & Johnson to $162 from $165 and keeps an Outperform rating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback